Laman Utama4536 • TYO
Santen Pharmaceutical Co Ltd
¥1,565.50
14 Jan, 6:15:03 PTG GMT+9 · JPY · TYO · Penafian
SahamSekuriti tersenarai JPIbu pejabat di JP
Tutup sebelumnya
¥1,537.50
Julat hari
¥1,542.50 - ¥1,580.00
Julat tahun
¥1,394.50 - ¥1,878.50
Permodalan pasaran
543.30B JPY
Bilangan Purata
1.43J
Nisbah P/E
21.31
Hasil dividen
2.17%
Pertukaran utama
TYO
Markah Perubahan Iklim CDP
B
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(JPY)Sep 2024Perubahan T/T
Hasil
71.63B-2.43%
Perbelanjaan pengendalian
29.41B-7.03%
Pendapatan bersih
8.14B-8.21%
Margin untung bersih
11.36-5.96%
Pendapatan bagi setiap syer
EBITDA
15.05B-12.75%
Kadar cukai berkesan
22.06%
Jumlah aset
Jumlah liabiliti
(JPY)Sep 2024Perubahan T/T
Pelaburan tunai dan jangka pendek
84.44B30.46%
Jumlah aset
409.08B-4.19%
Jumlah liabiliti
120.83B0.25%
Jumlah ekuiti
288.25B
Syer tertunggak
349.15J
Harga kepada buku
1.86
Pulangan pada aset
6.35%
Pulangan pada modal
9.02%
Perubahan bersih dalam tunai
(JPY)Sep 2024Perubahan T/T
Pendapatan bersih
8.14B-8.21%
Tunai daripada operasi
16.17B-35.81%
Tunai daripada pelaburan
-3.46B-219.37%
Tunai daripada pembiayaan
-13.29B-125.23%
Perubahan bersih dalam tunai
-5.30B-127.59%
Aliran tunai bebas
11.24B-49.67%
Perihal
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries. The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
Diasaskan
1890
Tapak web
Pekerja
3,744
Cari
Kosongkan carian
Tutup carian
Apl Google
Menu utama